title: Transplacental IgG subclass concentrations in pregnancies at risk of haemolytic disease of the newborn.
abstract: The relationship of haemolytic disease of the newborn (HDN) to the transplacental passage of the four IgG subclasses was assessed at various gestational ages by comparing the maternal and fetal IgG subclass concentrations in 34 pregnancies at risk of HDN with those in 30 pregnancies not at risk. Higher maternal and fetal IgG1 levels were attained in pregnancies at risk of HDN than in pregnancies not at risk. In contrast, a slight decrease in maternal IgG2 and IgG4 levels occurred in pregnancies at risk of HDN, as compared with a slight rise in maternal IgG2 and IgG4 levels in pregnancies not at risk of HDN. Changes in fetal IgG2 and 4 concentrations in either type of pregnancy were very similar, showing only slight increases between the 19th and 34th week of gestation. A slight decrease in maternal IgG3 occurred in both types of pregnancy. In contrast, higher and fairly steady levels of fetal IgG3 were observed in fetuses not at risk of HDN throughout gestation, when compared with those in 'at risk' pregnancies. However, the statistical reliability of these results is not clear since only small numbers of samples were tested and because wide variations in IgG concentrations were observed. The IgG subclass concentrations in 50 paired maternal and cord blood samples were also measured and revealed that IgG1 levels were substantially higher in cord rather than maternal blood; cord and maternal IgG2, 3 and 4 levels, on the other hand, were fairly similar.
authors.affiliation: North London Blood Transfusion Centre, Colindale, UK.
authors.forename: A
authors.initials: A
authors.lastname: Lubenko
authors.forename: M
authors.initials: M
authors.lastname: Contreras
authors.forename: C H
authors.initials: CH
authors.lastname: Rodeck
authors.forename: U
authors.initials: U
authors.lastname: Nicolini
authors.forename: J
authors.initials: J
authors.lastname: Savage
authors.forename: H
authors.initials: H
authors.lastname: Chana
mesh_terms: D004899:Erythroblastosis, Fetal / Q000276:immunology*; D005260:Female; D005312:Fetal Blood / Q000276:immunology*; D005865:Gestational Age; D006801:Humans; D007112:Immunity, Maternally-Acquired; D007074:Immunoglobulin G / Q000097:blood / Q000145:classification*; D007231:Infant, Newborn; D007518:Isoantibodies / Q000097:blood / Q000145:classification*; D008431:Maternal-Fetal Exchange; D011247:Pregnancy; D011248:Pregnancy Complications / Q000276:immunology*; D012203:Rh Isoimmunization / Q000097:blood / Q000276:immunology*; D012306:Risk
chemical_list: D007074:Immunoglobulin G; D007518:Isoantibodies